Validity and reliability of the EULAR instrument RAID.7 as a tool to assess individual domains of impact of disease in rheumatoid arthritis: a cross-sectional study of 671 patients
| Autor: | Gunnstein Bakland, Lena Bugge Nordberg, Siri Lillegraven, Espen A Haavardsholm, Erik Rødevand, Ulf Sundin, Nina Paulshus Sundlisater, Hallvard Fremstad, Tor Magne Madland, Åse Stavland Lexberg, Hilde Haukeland, Christian Høili, Hilde Stray, Anne Noraas Bendvold, Inger W Hansen |
|---|---|
| Přispěvatelé: | Gestionnaire, Hal Sorbonne Université, Centro Hospitalar e Universitário [Coimbra], Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto = University of Porto, Diakonhjemmet Hospital, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service de rhumatologie [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Auteur indépendant, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service de Rhumatologie [CHU Pitié Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Universidade do Porto, Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Service de rhumatologie [CHU Pitié Salpêtrière] (GRC-08 EEMOIS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU) |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
rheumatoid RAID Intraclass correlation Cross-sectional study [SDV]Life Sciences [q-bio] Immunology Validity Rheumatoid Arthritis Severity of Illness Index Etanercept law.invention Arthritis Rheumatoid 03 medical and health sciences 0302 clinical medicine Rheumatology law medicine Numeric Rating Scale Humans Immunology and Allergy 030212 general & internal medicine outcome assessment 030203 arthritis & rheumatology Sleep disorder business.industry Reproducibility of Results Construct validity medicine.disease health care 3. Good health [SDV] Life Sciences [q-bio] Cross-Sectional Studies arthritis patient reported outcome measures Physical therapy Medicine business medicine.drug |
| Zdroj: | RMD Open RMD Open : Rheumatic & Musculoskeletal Diseases RMD Open : Rheumatic & Musculoskeletal Diseases, BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩ RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2021, 7 (1), pp.e001539. ⟨10.1136/rmdopen-2020-001539⟩ RMD Open, Vol 7, Iss 1 (2021) |
| ISSN: | 2056-5933 |
| Popis: | ObjectiveThe rheumatoid arthritis impact of disease (RAID) questionnaire comprises seven patient-important domains of disease impact (pain, function, fatigue, sleep disturbance, emotional well-being, physical well-being, coping). RAID was validated as a pooled-weighted score. Its seven individual items separately could provide a valuable tool in clinical practice to guide interventions targeting the patient’s experience of the disease. The aim was to separately assess the psychometric properties of each of the seven numeric rating scale (NRS) of the RAID (RAID.7).Material and methodsPost hoc analyses of data from the cross-sectional RAID study and from the Rainbow study, an open-label 12-week trial of etanercept in patients with RA. Construct validity of each NRS was assessed cross-sectionally in the RAID data set by Spearman’s correlation with the respective external instrument of reference. Using the rainbow data set, we assessed reliability through intraclass correlation coefficient between the screening and the baseline visits and responsiveness (sensitivity to change) by standardised response mean between baseline and 12 weeks.ResultsA total of 671 patients with RA with features of established disease were analysed, 563 and 108 from RAID and Rainbow, respectively. The NRS correlated moderately to strongly with the respective external instrument of reference (r=0.62–0.81). Reliability ranged from 0.64 (0.51–0.74) (pain) to 0.83 (0.76–0.88) (sleep disturbance) and responsiveness from 0.93 (0.73–1.13) (sleep disturbance) to 1.34 (1.01–1.64) (pain).ConclusionThe separate use of the individual NRS of RAID (RAID.7) is valid, feasible, reliable and sensitive to change, representing an opportunity to improve the assessment and treatment of disease impact with minimal questionnaire burden.Trial registration numberNCT00768053. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|